AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitarite M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Eswar Therapeutics Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitarite M 50mg/500mg Tablet

Combiflex DM 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like renal failure and vision loss, potentially lowering heart attack and stroke risk. Combiflex DM 50mg/500mg may be used independently or with other diabetes treatments, and is most effective with a balanced diet and regular physical activity. Dosage is tailored to individual health, blood sugar readings, and existing medications. Consuming it with food minimizes stomach upset. Consistent daily dosing, at the same time, maximizes benefits; discontinuation should only occur under a physician's guidance. Adherence to your doctor's dietary and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Low blood sugar (hypoglycemia) is a potential side effect, especially with concurrent insulin or sulfonylurea use; learn to identify and manage it. This medication isn't for everyone. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or nursing individuals should seek medical advice. Interactions with other medications are possible; disclose all current medications for safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Sitarite M 50mg/500mg Tablet

Managing Type 2 diabetes

Major Benefits of Sitarite M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or divide it. Sitarite M 50mg/500mg tablets should be administered with food.

Common Side effects of Sitarite M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitarite M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Sitarite M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Sitarite M 50mg/500mg Tablet works:

Sitarite M, a 50mg/500mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action facilitates superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Sitarite M 50mg/500mg tablets and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitarite M 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Based on limited available data in humans, the use of Sitarite M 50mg/500mg tablets while breastfeeding is likely inadvisable due to a potential risk of the medication transferring to breast milk and causing harm to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitarite M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Sitarite M 50mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Use of Sitarite M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided unless specifically directed by a physician.

What if you forget to take Sitarite M 50mg/500mg Tablet :

Should you forget to take your Sitarite M 50mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitarite M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitarite M 50mg/500mg Tablet

Sitarite M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitarite M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitarite M 50mg/500mg Tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitarite M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitarite M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Sitarite M 50mg/500mg) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitarite M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitarite M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitarite M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitarite M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency resulting from high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms appear, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sitarite M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitarite M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitarite M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitarite M 50mg/500mg Tablets are contraindicated in patients with known allergies to any component or excipient. This medication should also be avoided by patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitarite M 50mg/500mg tablets is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin (like Sitarite M 50mg/500mg) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitarite M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitarite M 50mg/500mg Tab...
95
MRP 110
13% off